Potassium Chloride Extended-release Tablet
Product Images NDC 68001-566

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride Extended-release (NDC 68001-566). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride 10 Meq K 100 Count (Image 01)

Potassium Chloride 10 Meq K 100 Count (Image 01)
This is a medication produced by Granules India Limited in Hyderabad, India. The extended-release tablet contains 750mg of potassium chloride and is packaged in a tight, light-resistant container with a child-resistant closure. It is available in boxes with 100 tablets each, and should be stored at a controlled room temperature between 15°C to 25°C (59°F to 77°F). The medication is intended for oral use and should be kept out of reach of children.*
FDA Label Image

Potassium Chloride 20 Meq K 100 Count (Image 02)

Potassium Chloride 20 Meq K 100 Count (Image 02)
BN Granules India Limited manufactures potassium chloride extended-release tablets. The usual dosage should be determined by a healthcare professional. The tablets should be stored at room temperature and dispensed in a light-resistant container. It is important to keep the tablets out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.